Autosomal dominant glut-1 deficiency syndrome and familial epilepsy
- PMID: 11603379
- DOI: 10.1002/ana.1222
Autosomal dominant glut-1 deficiency syndrome and familial epilepsy
Abstract
Glut-1 deficiency syndrome was first described in 1991 as a sporadic clinical condition, later shown to be the result of haploinsufficiency. We now report a family with Glut-1 deficiency syndrome affecting 5 members over 3 generations. The syndrome behaves as an autosomal dominant condition. Affected family members manifested mild to severe seizures, developmental delay, ataxia, hypoglycorrhachia, and decreased erythrocyte 3-O-methyl-D-glucose uptake. Seizure frequency and severity were aggravated by fasting, and responded to a carbohydrate load. Glut-1 immunoreactivity in erythrocyte membranes was normal. A heterozygous R126H missense mutation was identified in the 3 patients available for testing, 2 brothers (Generation 3) and their mother (Generation 2). The sister and her father were clinically and genotypically normal. In vitro mutagenesis studies in Xenopus laevis oocytes demonstrated significant decreases in the transport of 3-O-methyl-D-glucose and dehydroascorbic acid. Xenopus oocyte membranes expressed high amounts of the R126H mutant Glut-1. Kinetic analysis indicated that replacement of arginine-126 by histidine in the mutant Glut-1 resulted in a lower Vmax. These studies demonstrate the pathogenicity of the R126H missense mutation and transmission of Glut-1 deficiency syndrome as an autosomal dominant trait.
Similar articles
-
Autosomal dominant transmission of GLUT1 deficiency.Hum Mol Genet. 2001 Jan 1;10(1):63-8. doi: 10.1093/hmg/10.1.63. Hum Mol Genet. 2001. PMID: 11136715
-
Functional studies of the T295M mutation causing Glut1 deficiency: glucose efflux preferentially affected by T295M.Pediatr Res. 2008 Nov;64(5):538-43. doi: 10.1203/PDR.0b013e318184d2b5. Pediatr Res. 2008. PMID: 18614966
-
Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects.Ann Neurol. 2005 Jan;57(1):111-8. doi: 10.1002/ana.20331. Ann Neurol. 2005. PMID: 15622525 Clinical Trial.
-
[Glucose transporter type 1 (GLUT-1) deficiency].Rev Neurol (Paris). 2008 Nov;164(11):896-901. doi: 10.1016/j.neurol.2008.02.033. Epub 2008 Apr 3. Rev Neurol (Paris). 2008. PMID: 18808765 Review. French.
-
[GLUT-1 deficiency syndrome].Rev Neurol. 2019 Aug 16;69(4):178-179. doi: 10.33588/rn.6904.2019126. Rev Neurol. 2019. PMID: 31334562 Review. Spanish.
Cited by
-
Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants.J Biol Chem. 2008 Jun 13;283(24):16732-42. doi: 10.1074/jbc.M801403200. Epub 2008 Apr 3. J Biol Chem. 2008. PMID: 18387950 Free PMC article.
-
Changes in Nutritional Status Impact Immune Cell Metabolism and Function.Front Immunol. 2018 May 16;9:1055. doi: 10.3389/fimmu.2018.01055. eCollection 2018. Front Immunol. 2018. PMID: 29868016 Free PMC article. Review.
-
Molecular Dynamics Simulations of the Human Glucose Transporter GLUT1.PLoS One. 2015 Apr 28;10(4):e0125361. doi: 10.1371/journal.pone.0125361. eCollection 2015. PLoS One. 2015. PMID: 25919356 Free PMC article.
-
Glut1 deficiency: inheritance pattern determined by haploinsufficiency.Ann Neurol. 2010 Dec;68(6):955-8. doi: 10.1002/ana.22088. Ann Neurol. 2010. PMID: 20687207 Free PMC article.
-
Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality.Sci Transl Med. 2011 Aug 3;3(94):94ra70. doi: 10.1126/scitranslmed.3002394. Sci Transl Med. 2011. PMID: 21813754 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous